AcouSort AB engages in the provision of biotechnology. It offers solutions for automated sample preparations involving biological cells or other organelles. The firm's activities include development and commercialization of proprietary bioanalytical and clinical applications based on acoustophoresis including AcouTrap, AcouPlasma, and AcouWash. The company was founded by Lars Thomas Laurell, Patrik Brundin, Hans Lilja, and Stefan Scheding in December 2010 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company